| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Revenue | $788.9M | +25.8% |
| Cost of Revenue | $565.6M | +17.8% |
| Gross Profit | $223.4M | +52.0% |
| R&D Expense | $635K | -6.9% |
| SG&A Expense | $167.4M | +1.3% |
| Operating Income | -$174.7M | +87.2% |
| Interest Expense | $49.3M | +5.7% |
| Pre-tax Income | -$249.0M | +82.8% |
| Income Tax | -$26.6M |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $228.3M | +10.5% |
| Short-term Investments | $32.2M | -86.7% |
| Accounts Receivable | $101.7M | +17.9% |
| Inventory | $252.1M | +25.7% |
| Current Assets | $677.7M | -12.3% |
| Total Assets | $4.22B | -2.0% |
| Current Liabilities | $299.2M | -30.9% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.9M | -490.9% |
| Investing Cash Flow | $128.3M | +145.0% |
| Financing Cash Flow | -$75.2M | -207.2% |
| -270.6% |
| Net Income | -$245.0M | +83.1% |
| EPS (Basic) | -$0.33 | +86.0% |
| EPS (Diluted) | -$0.33 | +86.0% |
| Total Liabilities |
| $778.5M |
| -20.3% |
| Stockholders' Equity | $3.44B | +3.8% |